Time Magazine Releases Cover Story on Pain Killers

Time Magazine Releases Cover Story on Pain Killers

BY ADMIN /   TUESDAY, 15 DECEMBER 2015 /

The June 15 issue of Time Magazine is out with a cover story on Pain Killers that says America’s addiction to them is the worst addiction crisis the country has ever seen.

Calling it a national epidemic, it says “9.4 million Americans take opioids for long-term pain and 2.1 million are estimated by the NIH (National Institutes of Health) to be hooked.”

The article written by Massimo Calabresi calls the crisis a “tragic combination of good intentions, criminal deception and feckless oversight to turn America’s desire to relieve its pain into such widespread suffering.”

It recounts how the FDA approved ever more powerful drugs for long-term use without enough data, the pharmaceutical companies marketed aggressively, and doctors wrote the prescriptions too freely.

The article doesn’t speak much to the issue of chronic pain, for which many prescriptions are written, other than to say 100-million people suffer from it and a quarter of them says it is severe enough to limit their quality of life, according to the Institutes of Medicine.

The National Pain Report ran a story in April asking if the media are missing the point on the pain medication dispute and cited two pain leaders who agreed that prescription drug abuse is a problem, but that pain patients who need the medication and use it responsibly needs to be remembered in the discussion.

The Time article really concentrated on the addiction and the lack of science it says exists. Calabresi writes:

“Part of the problem, according to the NIH, is that doctors have no scientific certainty over when and whether it’s safe to use opioids to treat long-term pain. “There is insufficient evidence for every clinical decision that a provider needs to make regarding use of opioids for chronic pain,” a NIH panel on opioids concluded earlier this year. The American Academy of Neurology last year concluded that the risks of long-term opioid treatment for headaches and chronic low-back pain likely outweigh the benefits.”

The lack of science both retrospectively and going forward was cited in the story.

“There were no reliable studies proving opioids worked safely against chronic pain, because it would be unethical to require pain patients in a control group to go months on end without medication. “It’s not practical for us to require people to go for a year on a placebo,” says Janet Woodcock, head of the FDA’s Center for Drug Evaluation and Research”

The Time article also says the issue is starting to percolate in the nascent 2016 presidential campaign. Hilary Clinton is talking about the “quiet epidemic” and Carly Fiorina, whose late daughter struggled with painkillers, has call for decriminalizing drug addiction.

Integrity Life Sciences delivers a multitude of orthotic treatment options to address one of the most costly systemic ailments in the world, chronic low back and neck pain. Our advanced solution begins with the Integrity Spinal Care System (ISCS) ™ and its proprietary iELCiPS Technology™. The ISCS non-surgical spinal decompression modality systems are engineered to provide pain relief for compressive and degenerative conditions of the spine. Specifically, conditions that may be treated include: neck pain and back pain associated with herniated discs, protruding discs, degenerative disc disease, posterior facet syndrome, and sciatica. It achieves these effects through decompression of intervertebral discs, that is, unloading due to distraction and positioning.

As a compliment to the ISCS, Integrity offers the very effective Integrity Gel Support Brace™. Our advanced lumbar support brace is a fitting compliment to non-surgical spinal decompression therapy and was designed as an adjunct therapy for those suffering from back pain due to disc related conditions. The Integrity Gel Support Brace may be used with or without Integrity’s non-surgical spinal decompression systems and is an excellent treatment option for the patient to use at home.

In addition, Integrity Life Sciences has been exclusively granted the use of all of the technology, products, US Patent and Trademark Office’s assignments, logos and other forms of intellectual property that were created by Axiom Worldwide, INC under the leadership of Jim Gibson from Tampa, Florida. The agreement specifically includes the flagship product DRX 9000™, its family of products, and all of its derivatives such as the DRX9000C. Integrity offers support for these products, which includes: sales, maintenance services, and repairs. Only Integrity Life Sciences is Registered with the US FDA as a Factory Authorized – Contract Manufacturer – for Axiom Worldwide and the DRX9000 True Non-Surgical Spinal Decompression Systems™

James Gibson, President of Integrity Life Sciences and Axiom Worldwide states “Our partners, in over 50 countries and territories, have the unique opportunity to present a cutting edge medical device, utilizing a clinically validated protocol that restores a patient’s quality of life non-surgically and without pharmaceutical or invasive intervention“. With a body of published clinical research from around the world will support and strengthen your sales presentation; members of our medical advisory board herald from prestigious institutions such as Johns-Hopkins and The Mayo Clinic just to name a few. In addition, partners will have confidence in a quality product that adheres to the stringent standards mandated by FDA, CE, and ISO. Sales, marketing, and technical training is offered in prestigious locations in Europe, Asia, the Middle East and throughout the United States.

Learn more @: www.IntegrityLifeSciences.com or www.AxiomWorldwide.com

Integrity Life Sciences, LLC and Axiom Worldwide, INC are privately held companies with global interests and shareholders with international partners located across the globe with a mission of “Restoring Integrity to the Spine™” and delivering "True Non-Surgical Spinal Decompression"

For additional information please visit: www.IntegrityLifeSciences.com.

Elements as Published in: Time Magazine